Q1 FY26-27 results: PAT up on consol basis, standalone revenue dips

Revenue declinedResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.8%Reaction day

₹14.20

prior close

₹14.95

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-5.9% vs market

Healthcare Service Provider peers, median of 26sector-2.0%-3.8% vs sector

On the reaction day the stock moved 5.9 pts less than Nifty Microcap 250 and 3.8 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.3

15m

-1.4

30m

-6.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.8+0.1-5.9-2.0-3.8

Next day

-7.6+0.2-7.8-0.3-7.3

-3.9+0.6-4.5-0.3-3.7

-7.7-0.0-7.7-3.7-4.1

-7.3+0.5-7.8-2.3-5.1

-6.7+0.8-7.5-2.1-4.6

+0.3+0.6-0.3-0.4+0.7

15d

-1.8+1.3-3.1+1.7-3.5

-4.4-1.4-3.0+0.1-4.5

-5.8-0.6-5.2-5.2-0.6

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Tejnaksh Healthcare posted Q1 FY26-27 unaudited results. Consolidated revenue rose slightly to 265.39 lakhs from 263.97. Consolidated PAT climbed to 26.07 lakhs from 21.27, up about 22.6%. Standalone revenue dipped to 255.29 lakhs and standalone PAT fell to 29.11 lakhs from 33.73. EPS stood at 0.13 consolidated and 0.14 standalone. Auditor Maheshwari and Co issued an unmodified limited review on both sets.

Likely market impact

Consolidated profit growth is a positive, though standalone revenue and PAT declined year on year.